Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for Prevention of Miscarriage and Preterm Birth (PREEMPT)
NCT02145767Phase 2Completed
- Sponsor
- Jewish General Hospital
- Start
- Dec 2014
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of progesterone in spontaneous abortion, preterm birth, sponsored by Jewish General Hospital. Started Dec 2014; status: completed.
02
Drugs
progesterone
03
Conditions
spontaneous abortionpreterm birth
Beyond the preview
Go deeper on NCT02145767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145767.